REMPARK: When AI and technology meet Parkinson Disease assessment
暂无分享,去创建一个
Juan Manuel Moreno | Joan Cabestany | Albert Samà | Carlos Pérez-López | Àngels Bayés | Alejandro Rodríguez-Molinero
[1] P. Asselman,et al. An ambulatory dyskinesia monitor , 2000, Journal of neurology, neurosurgery, and psychiatry.
[2] John Seibyl,et al. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group. , 2000, JAMA.